Department of Pediatrics and Medical Genetics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):181-189. doi: 10.47162/RJME.63.1.19.
Tuberous sclerosis complex (TSC) is a rare autosomal dominant condition characterized by cutaneous, cerebral, and other multiorgan involvement. Aneurysms due to TSC pathogenic mechanism are rarely present, mainly aortic, renal, or intracranial and very few associated with peripheral circulation. A TSC patient, aged 31 years, who developed brachial and subclavian arteries aneurysms is presented. The question of a random association of the aneurysms with TSC versus aneurysms within pathogenic released mammalian target of rapamycin (mTOR) pathway effect was raised.
Patient's file, available from the age of six months, was analyzed for demonstration of the TSC diagnosis. Patient was examined, and cerebral magnetic resonance imaging (MRI) was repeated. Surgery and angiographic reports and images were reviewed. Pathology of the aneurysmal wall available from surgery was reexamined and special stainings and immunohistochemistry markers were applied. Genetic characterization of the patient was performed. Definite TSC was diagnosed based on major criteria [ungual fibromas, shagreen patch, cortical tubers, subependymal nodules (SENs), subependymal giant cell astrocytoma (SEGA)], minor criteria (confetti skin lesions, dental enamel pits, gingival fibromas), genetic result showing heterozygous variant in exon 8 of TSC1 gene (c.733C>T-p.Arg245*). Pathology analysis revealed markedly thickened aneurysmal wall due to smooth muscle cells (SMCs) proliferation in media and neoformation vessels with similar characteristics in the aneurysmal wall.
This is a rare case with aneurysms related to TSC, with an exceptional peripheral localization. Pathology exam is the key investigation in demonstrating the TSC-related pathogenic mechanism. A literature review showed 73 TSC cases presenting aneurysms published until now.
结节性硬化症(TSC)是一种罕见的常染色体显性遗传疾病,其特征为皮肤、脑部和其他多器官受累。由于 TSC 发病机制导致的动脉瘤很少见,主要发生在主动脉、肾脏或颅内,极少数与周围循环有关。本文介绍了一位 31 岁的 TSC 患者,其出现了肱动脉和锁骨下动脉的动脉瘤。提出了这些动脉瘤是随机与 TSC 相关,还是与哺乳动物雷帕霉素靶蛋白(mTOR)通路相关的致病性释放有关的问题。
分析了患者从 6 个月大时起的病历,以证明 TSC 的诊断。对患者进行了检查,并重复进行了脑部磁共振成像(MRI)检查。对手术和血管造影报告和图像进行了审查。对手术中获得的动脉瘤壁的病理进行了重新检查,并应用了特殊染色和免疫组织化学标志物。对患者进行了基因特征分析。根据主要标准[甲下纤维瘤、沙仑斑、皮质结节、室管膜下结节(SENs)、室管膜下巨细胞星形细胞瘤(SEGA)]、次要标准(斑驳状皮肤病变、牙釉质凹陷、牙龈纤维瘤)和基因结果(TSC1 基因外显子 8 中的杂合变体 c.733C>T-p.Arg245*)诊断为明确的 TSC。病理学分析显示,中膜平滑肌细胞(SMCs)增殖导致动脉瘤壁明显增厚,以及动脉瘤壁中具有相似特征的新生血管。
这是一例罕见的与 TSC 相关的动脉瘤病例,具有特殊的外周定位。病理学检查是证明 TSC 相关发病机制的关键检查。文献回顾显示,迄今为止已发表了 73 例 TSC 病例伴有动脉瘤。